Movatterモバイル変換


[0]ホーム

URL:


Skip to main content
NCBI home page
Search in PMCSearch
As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health.
Learn more:PMC Disclaimer | PMC Copyright Notice
Medical Hypothesis, Discovery and Innovation in Ophthalmology logo
. 2015 Summer;4(2):39–49.

Age-Related Macular Degeneration: A Scientometric Analysis

Shahrokh Ramin1,Masoud Soheilian1,Gholamreza Habibi2,Roghayeh Ghazavi2,Reza Gharebaghi3,Fatemeh Heidary3
1Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2Farzan Scientometric Group, Farzan Clinical Research Institute, Tehran, Iran
3Health Policy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

Correspondence to: Dr Shahrokh Ramin. Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran, Phone: +98 21 22591616, Fax: +98 21 22590607, Email: dr.ramin1346@gmail.com

© 2015, Medical Hypothesis, Discovery & Innovation (MEHDI) Ophthalmology Journal

This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMCID: PMC4458325  PMID:26060829

Abstract

Age-related macular degeneration (ARMD) is a major cause of central blindness among working aged adults across the world. Systematic research planning on any subject, including ARMD is in need of solid data regarding previous efforts in this field and to identify the gaps in the research. This study aimed to elucidate the most important trends, directions, and gap in this subject.

The data extracted from the Institute for Scientific Information were used to perform a bibliometric analysis of the scientific productions (1993–2013) about ARMD. Specific parameters related to ARMD were analyzed to obtain a view of the topic’s structure, history, and document relationships. Additionally, the trends and authors in the most influential publications were analyzed.

The number of articles in this field was found constantly increasing. Most highly cited articles addressed genetic epidemiology and clinical research topics in this field. During the past 3 years, there has been a trend toward biomarker research.

Through performing the first scientometric survey on ARMD research, we analyzed the characteristics of papers and the trends in scientific production. We also identified some of the critical gaps in the current research efforts that would help in large-scale research strategic planning.

Key Words: Age-related Macular Degeneration, Bibliometrics, Historiography, Scientometrics, Citation Analysis

INTRODUCTION

Age-related macular degeneration (ARMD) is one of the top four causes of blindness in elderly people. ARMD, described more than 80 years ago, is a progressive disease of the central area in the ocular posterior segment (the macula lutea), which leads to a gradual deterioration in central vision and causes severe disability to affected individuals. In North America, Europe, and Australia, ARMD accounts for up to half of all cases of central blindness, affecting approximately 3% of the general adult population. In the United States, about 12%–15% of people older than 80 years of age were estimated to have ARMD in 2000, and this number is expected to be more than 2.95 million in 2020. People with ARMD have been found to experience reduced quality of life, depression, and difficulty with the activities of daily living, which pose serious financial burden on their family in terms of high medical and societal costs that are due to increased risk of falling, need for vision enhancing equipment, depression/anxiety treatment, and assistance with activities of daily living (1,2).

Visual loss in late ARMD can be caused by either of the following two processes that cause photoreceptor dysfunction: geographic atrophy (GA) or choroidal neovascularization. GA refers to the confluent atrophy of the choriocapillaris and associated retinal pigment epithelium (RPE). The RPE is the outermost layer of the retina, which is involved in phagocytosis of the photoreceptor outer segments and biologic maintenance. In choroidal neovascularization, an ingrowth of new vessels occurs from the choriocapillaris invading the retina. These new vessels leak serous fluids beneath and into the neural retina causing fibrous scarring, which defines the late stage of ARMD (exudative, or neovascular) (3). Non-exudative (dry) ARMD is often marked by the formation of drusen, pigmentary changes in the RPE, and atrophy of the RPE. Dry ARMD is more common; in one series of autopsy eyes, ARMD was found in 33% of patients older than 65 years (4,5).

The incidence of the disease increases with age. Through major breakthrough discoveries made in the last decade in treating the wet form of ARMD, the chance of stabilizing or increasing vision has been increased to 90%. Nonetheless, this improvement is associated with a significant price tag of monthly intravitreal injections (with the ever-present phantom of endophthalmitis and other injection-related adverse events) and uncertainty regarding the duration of treatment (6).

A scientometrics method is one that measures and analyzes scientific publications related to a specific topic regarding the trends in citations, most important content, authors, and journals. A widespread use of scientometric method goes back to 1960s when Eugene Garfield finalized the construction of Science (7). In this article, we performed the first scientometric analysis of the ARMD field to elucidate the most important trends and directions of this subject.

MATERIAL AND METHODS

A bibliometric study was performed on the articles related to “Age-Related Macular Degeneration” published between 1993 and 2013. The Institute for Scientific Information (ISI) web of science available at http://www.isiknowledge.com was our main source. Two mesh terms—“Age-Related Macular Degeneration” and “ARMD”—already checked in Pubmed mesh database were used to conduct the search.

Only original articles were selected for further evaluation. These articles were evaluated regarding citation characteristics, contributing role of each author, country, funding agency, institution, journal, and language of published articles. Articles were also evaluated regarding the trend of publication and citation during a selected time and also subject areas covered. Articles that were published in 10 countries with the greatest number of publications on the topic were analyzed separately.

Articles published by each country were evaluated regarding subject areas and publishing journals. Special attention was paid to total citations with and without self-citation, citation per year, and citation per item for journals of each country. Articles that were cited more than 100 times were evaluated regarding year of publication, country of affiliation of the first author, and publishing journal. Number, country, and year of collaborative studies were also considered. All three resources available in the ISI web of science were used for this purpose (Science Citation Index Expanded, Social Sciences Citation Index, The Arts & Humanities Citation Index). For the citation analysis, two parameters were calculated: Local Citation Score (LCS) and Global Citation Score (GCS). LCS listed all papers sorted by citation frequency within the local (the starting bibliography) collection; however, GCS counted citations in the whole collection. For the citation burst analysis, first, 100 key words that generated the citation bursts were extracted, and then non-specific and general key words were omitted.

RESULTS

Annual Publication Number During 1993-2013

A total of 3235 research articles were available on ARMD in the ISI Web of Science during 1993-2013. These papers were drafted by 10,706 authors, 2332 institutions, and 67 countries and were published in 388 journals in 9 languages.Figure 1 demonstrates the growth rate of publications in this field (14.46% per year). The H-index of this subject was 125.

Figure 1.

Annual Number of Published Papers

Figure 1

The growth rate of 14.6% in the article numbers was observed.

Citation Profile of Articles

The total LCS citations were 29,924 in number and GCS citations were 91,840 in number. The average citation per paper (C/P) was 28.39

Table 1 shows the articles that were cited 100 or more times.Figure 2 shows the trend of citations during the period. Appendix 1 shows the highly cited articles in this field.Figure 1 shows the histogram map of 20 years of research in this field.

Table 1.

Articles With Highest Number of Citations

#Author/ Title / JournalCITATION
1Klein Rj, Zeiss C, Chew Ey, Tsai Jy, Sackler Rs, Et Al.
Complement Factor H Polymorphism In Age-Related Macular Degeneration
Science. 2005 Apr 15; 308 (5720): 385-389
1814
2Rosenfeld Pj, Brown Dm, Heier Js, Boyer Ds, Kaiser Pk, Et Al.
Ranibizumab For Neovascular Age-Related Macular Degeneration
New England Journal Of Medicine. 2006 Oct 5; 355 (14): 1419-1431
1662
3Edwards Ao, Ritter R, Abel Kj, Manning A, Panhuysen C, Et Al.
Complement Factor H Polymorphism And Age-Related Macular Degeneration
Science. 2005 Apr 15; 308 (5720): 421-424
1173
4Brown Dm, Kaiser Pk, Michels M, Soubrane G, Heier Js, Et Al.
Ranibizumab Versus Verteporfin For Neovascular Age-Related Macular Degeneration
New England Journal Of Medicine. 2006 Oct 5; 355 (14): 1432-1444
1161
5Haines Jl, Hauser Ma, Schmidt S, Scott Wk, Olson Lm, Et Al.
Complement Factor H Variant Increases The Risk Of Age-Related Macular Degeneration
Science. 2005 Apr 15; 308 (5720): 419-421
1148
6Gragoudas Es, Adamis Ap, Cunningham Et, Feinsod M, Guyer Dr
Pegaptanib For Neovascular Age-Related Macular Degeneration
New England Journal Of Medicine. 2004 Dec 30; 351 (27): 2805-2816
1146
7Kassoff A, Kassoff J, Buehler J, Eglow M, Kaufman F, Et Al.
A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation With Vitamins C And E, Beta Carotene, And Zinc For Age-Related Macular Degeneration And Vision Loss - Areds Report No. 8
Archives Of Ophthalmology. 2001 Oct; 119 (10): 1417-1436
1081
8Bressler Nm
Photodynamic Therapy Of Subfoveal Choroidal Neovascularization In Age-Related Macular Degeneration With Verteporfin - One-Year Results Of 2 Randomized Clinical Trials - Tap Report 1
Archives Of Ophthalmology. 1999 Oct; 117 (10): 1329-1345
1021
9Friedman Ds, O'colmain B, Tomany Sc, Mccarty C, De Jong Ptvm, Et Al.
Prevalence Of Age-Related Macular Degeneration In The United States
Archives Of Ophthalmology. 2004 Apr; 122 (4): 564-572
970
10Hageman Gs, Anderson Dh, Johnson Lv, Hancox Ls, Taiber Aj, Et Al.
A Common Haplotype In The Complement Regulatory Gene Factor H (Hf1/Cfh) Predisposes Individuals To Age-Related Macular Degeneration
Proceedings Of The National Academy Of Sciences Of The United States Of America. 2005 May 17; 102 (20): 7227-7232
929

Figure 2.

Figure 2

Histogram Map of 20 Years of Research in ARMD

Figure 3 shows the key words generating the highest citation bursts and the time periods associated with them. The key words associated with the highest citation bursts included: drusen, choroidal neovascular membranes, subfoveal neovascular membranes, neovascularization, subretinal neovascularization, blindness, fluorescein angiography, retinal pigment epithelium, choroidal perfusion abnormality, indocyanine green angiography, dystrophy, Beaver dam eye, Bruch membrane change, angiography, neovascular membranes, radiation therapy, photocoagulation, videoangiography, indocyanine green videoangiography, occult choroidal neovascularization, choriocapillaris, teletherapy, retinitis pigmentosa, Stargardt disease, mutations, apolipoprotein E, subfoveal choroidal neovascularization, laser photocoagulation, genome-wide scan, susceptibility loci, verteporfin therapy, c-reactive protein, avastin, pegaptanib, ranibizumab, polypoidal choroidal vasculopathy, complement factor H, bevacizumab, optical coherence tomography, polymorphism, endothelial growth factor, and vascular endothelial growth factor.

Figure 3.

Figure 3

Citation Burst Analysis

Subject Analysis of the Most Highly Cited Documents

The most common topics of the top 10 highly cited papers were genetic epidemiology research (40%), clinical study (surgical or pharmaceutical treatment) (50%), and epidemiologic study (10%) (Table 1).Languages, Journal Subjects, and Author Profiles of Publications

Most ARMD articles were in English (3068), followed by German (105) and French (47). In total, the articles were written in nine languages (English, German, French, Portuguese, Hungarian, Spanish, Polish, Serbian, and Slovene). Dr R. Klein, with 80 articles, had the largest number of publications in the field of ARMD research (Table 2). When analyzed based on the number of papers in ARMD, 8 out of top 10 journals were general medical journals (such as the New England Journal of Medicine) and the remaining were ophthalmology journals. But when the same calculation was made based on the citation number (TLCS), seven journals were general medical journals and three were ophthalmology journals. When analyzed based on TGCS, highly cited papers were mostly published in general medical journals (80%), and the remaining 20% were published in Ophthalmology journals (Tables 3). No correlation was found between the impact factor of the most highly influential journals in this field and the total citations they had received for their papers in the field of ARMD.

Table 2.

Most Active Authors in the Field of ARMD Research

#AuthorRecsTLCSTGCS
1Klein R8024056370
2Bressler Nm76363910146
3Mitchell P6313003350
4Soubrane G6012023152
5Seddon Jm5822696377
6Schmidt-Erfurth U5615114504
7Holz Fg555502187
8Guymer Rh52310855
9Wong Ty524221004
10Bressler Sb4825466735

Table 3.

Journals with Highest Number of Papers in This Field

#JournalRecordsCitation2 year IF5 year IF
1Ophthalmology289126245.5635.777
2Investigative Ophthalmology & Visual Science27474213.4413.730
3American Journal Of Ophthalmology23280433.6314.292
4Retina-The Journal Of Retinal And Vitreous Diseases22539332.8252.761
5British Journal Of Ophthalmology19844622.7253.023
6Archives Of Ophthalmology166133693.8264.160
7Graefes Archive For Clinical And Experimental Ophthalmology12525501.9322.037
8Eye9710151.8181.883
9Molecular Vision7312101.9872.311
10Acta Ophthalmologica654082.3452.428
11Ophthalmologica575031.4121.236
12Klinische Monatsblatter Fur Augenheilkunde491970.6990.473
13Ophthalmologe482950.5290.681
14European Journal Of Ophthalmology462960.9120.963
15Journal Francais D Ophtalmologie451120.4380.443
16Japanese Journal Of Ophthalmology432341.2741.488
17PLose One434933.7304.244
18Ophthalmic Surgery Lasers & Imaging396341.4640.922
19Canadian Journal Of Ophthalmology-Journal Canadien D Ophtalmologie383981.1451.320
20Clinical And Experimental Ophthalmology282911.9642.047

A majority of the top 10 universities and institutions in the list are from the United States and Australia. The first two of them are the Johns Hopkins University and University of Melbourne in terms of number of documents and Harvard University and University of Wisconsin in terms of number of citations (Table 4).

Table 4.

Institutions with Highest Number of Papers

#InstitutionRecordsCitations
1Johns Hopkins Univ1307472
2Univ Melbourne1253103
3Harvard Univ1179211
4Duke Univ974450
5Univ Wisconsin976462
6Nei866282
7Univ Sydney793584
8Moorfields Eye Hosp732029
9Univ Penn733241
10Univ Southern Calif681737
11Univ Heidelberg641960
12Univ Miami575242
13UCL541273
14Univ Paris 12532140
15Natl Univ Singapore51809
16Univ Cologne501054
17Univ Utah492540
19Univ Iowa483215
20Univ Bonn471190

Geographical Distribution

In general, 67 countries contributed to the promotion of the field of ARMD by publishing articles. The United States, Germany, and the UK had the highest number of documents but they had the highest number of citations to their research papers in the field of ARMD (Table 5).

Table 5.

Countries With Highest Number of Papers in the Field of ARMD

#CountryRecsCITATION
1USA133860915
2Germany3638968
3UK3409990
4Australia2156031
5Japan1933740
6France1634862
7Peoples R China1442486
8Italy1201842
9Austria1123371
10Unknown1052707
11Canada973205
12Switzerland922959
13Netherlands744699
14Spain651184

Discussion

We analyzed the subject of highly cited papers, dividing them into two broad categories: epidemiology versus clinical research and translational versus basic science research (Appendix 1). Most of the highly cited papers were genetic epidemiology or clinical reports. Although ARMD is a debilitating disease and adversely affects the quality of life and emotional status of subjects, highly cited papers had largely neglected this subject. Highly cited reports also addressed the following subjects more frequently: (1) association of various genotypes with ARMD, (2) chemotherapy for wet ARMD, including the intravitreal treatment, and (3) effect of diet and vitamins on ARMD. Recently, as Appendix 2 shows, there has been a trend toward more applicable genetic epidemiology and translational research (biomarkers). In cluster analysis for the citations, we found the following three major clusters in the citation histogram map (Figure 1): (1) complement H factor polymorphism in the ARMD (nodes 831, 832, 833, and 842 in the index 1), (2) treatment of subfoveal choroidal neovascularization in ARMD (nodes 386, 402, and 428), and (3) ranibizumab treatment for neovascular ARMD (nodes 1116 and 1117).

Proportionally, articles related to medical retina compared to other subspecialties have increased between 2005 and 2009. In an analytical study of the ophthalmology research papers, case–control or cohort studies comprised most study designs used (40.1%), followed by non-analytic studies (28.7%), basic science (24.6%), RCTs (3.3%), review articles (2.6%), and meta-analyses (0.3%) (8). However, the trend was not similar in the ARMD research for the highly cited papers. As Graph 3 shows, in the 1990s, the key words that resulted in the most strong citation bursts were the ones associated with pathophysiology, such as subretinal neovascularization; however, in the past 4 years, there has been a trend toward novel treatments such as ranibizumab in the context of RCTs, which shows the importance of this line of research and also the progression in the field of ARMD. Both the citation burst analysis and the histography of the most cited papers in the past 3 years showed that genetic epidemiology topics are among the recent hot topics in this field. Interestingly, genetic epidemiology studies also comprised the most highly cited articles in the past 20 years, which implies that this field is still hot and many more studies have a high chance of publication in this field.In our study, the number of citations correlated poorly with the impact factor of the journals. Citation frequency and impact factor both render important information regarding the merit of a paper, but the ranking of research groups on the basis of journal impact factor is shown to have little correlation with the ranking of the same groups on the basis of citation frequency. This can be due to the fact that journals with an advance online publication had higher impact factors compared with those without an advance online publication. Also, researchers might prefer to publish their results in their subspecialty journal, which might not necessarily have a high impact factor. It is suggested that “citation analysis is a good rough indicator of the quality of work as it is perceived by other scientists” (9). Previously, two detailed citation analysis reports have been published, one spanning the period of 1850–1949 (10) and the other 1975–2006 (11). In both reports, ARMD was a major citation classic, especially for ophthalmology journals. The second report surveyed 46 ophthalmology journals and concluded that the 100 most cited articles were published in 13 journals, including the Archives of Ophthalmology, Ophthalmology, and the American Journal of Ophthalmology (11). Epidemiology of ARMD was one of the major topics of 100 most cited articles. Also we found that the H-index of ARMD was 125, which indicates the appreciation of the context of ARMD within vision research. The publications of Dr Klein and several other top researchers in the field of ARMD research are also among the top 100 most cited articles in the field of Ophthalmology, which shows the importance of this field.

Several lines of research have been previously identified as priorities in ARMD research. These include temporal patterns and changing the prevalence of ARMD; improvements of ocular imaging (eg, high-resolution OCT) to allow better phenotype classification of both early and late ARMD; and epidemiologic studies to determine gene-environment interactions for ARMD to identify early modifiable risk factors to prevent ARMD (12). According to the results of our study, several of these areas do not receive enough attention from the experts in the field, and better research strategies should be implemented.

In conclusion, the result of our report as the first scientometric analysis of the research on ARMD can be used as a guideline for authors, researchers, and policy makers to determine the best ways to allocate their financial and workforce resources.

DISCLOSURE

The authors report no conflicts of interest in this work.

References

  • 1.Parmeggiani F, Romano MR, Costagliola C, Semeraro F, Incorvaia C, D'Angelo S, Perri P, De Palma P, De Nadai K, Sebastiani A. Mechanism of inflammation in age-related macular degeneration. Mediators Inflamm. 2012;2012 doi: 10.1155/2012/546786. PMID: 23209345 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Bennion AE1, Shaw RL, Gibson JM. What do we know about the experience of age related macular degeneration? A systematic review and meta-synthesis of qualitative research. Soc Sci Med. 2012 Sep;75(6):976–85. doi: 10.1016/j.socscimed.2012.04.023. PMID: 22709445. [DOI] [PubMed] [Google Scholar]
  • 3.Wong TY, Chakravarthy U, Klein R, Mitchell P, Zlateva G, Buggage R, Fahrbach K, Probst C, Sledge I. The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis. Ophthalmology. 2008 Jan;115(1):116–26. doi: 10.1016/j.ophtha.2007.03.008. Epub 2007 Aug 6. PMID: 17675159. [DOI] [PubMed] [Google Scholar]
  • 4.Schiffelers RM1, van der Vaart TK, Storm G. Neovascular age-related macular degeneration: opportunities for development of first in classbiopharmaceuticals. BioDrugs. 2011 Jun 1;25(3):171–89. doi: 10.2165/11589330-000000000-00000. PMID: 21627341. [DOI] [PubMed] [Google Scholar]
  • 5.Telander DG. Inflammation and age-related macular degeneration (AMD) Semin Ophthalmol. 2011 May;26(3):192–7. doi: 10.3109/08820538.2011.570849. PMID: 21609232. [DOI] [PubMed] [Google Scholar]
  • 6.Velez-Montoya R1, Oliver SC, Olson JL, Fine SL, Mandava N, Quiroz-Mercado H. Current knowledge and trends in age-related macular degeneration: today's and future treatments. Retina. 2013 Sep;33(8):1487–502. doi: 10.1097/IAE.0b013e318271f265. PMID: 23222393. [DOI] [PubMed] [Google Scholar]
  • 7.Garfield E. ‘‘Science Citation Index’’—a new dimension in indexing. Science. 1964;144:649–654. doi: 10.1126/science.144.3619.649. [DOI] [PubMed] [Google Scholar]
  • 8.Kumar A, Cheeseman R, Durnian JM. Subspecialization of the ophthalmic literature: a review of the publishing trends of the top general. Ophthalmology. 2011;118(6):1211–4. doi: 10.1016/j.ophtha.2010.10.023. PMID: 21269704. [DOI] [PubMed] [Google Scholar]
  • 9.Ogden TL, Bartley DL. The ups and downs of journal impact factors. Ann Occup Hyg. 2008 Mar;52(2):73–82. doi: 10.1093/annhyg/men002. PMID: 18316351. [DOI] [PubMed] [Google Scholar]
  • 10.Ohba N, Nakao K. The 101 most frequently cited articles in ophthalmology journals from 1850 to 1949. Arch Ophthalmol. 2010 Dec;128(12):1610–7. doi: 10.1001/archophthalmol.2010.308. doi: 10.1001/archophthalmol.2010.308. PMID: 21149789. [DOI] [PubMed] [Google Scholar]
  • 11.Ohba N, Nakao K, Isashiki Y, Ohba A. The 100 most frequently cited articles in ophthalmology journals. Arch Ophthalmol. 2007 Jul;125(7):952–60. doi: 10.1001/archopht.125.7.952. PMID: 17620577. [DOI] [PubMed] [Google Scholar]
  • 12.Wong TY, Hyman L. Population-based studies in ophthalmology. Am J Ophthalmol. 2008 Nov;146(5):656–63. doi: 10.1016/j.ajo.2008.07.048. doi: 10.1016/j.ajo.2008.07.048. PMID: 18984085. [DOI] [PubMed] [Google Scholar]

Articles from Medical Hypothesis, Discovery and Innovation in Ophthalmology are provided here courtesy ofInternational Virtual Ophthalmic Research Center

ACTIONS

RESOURCES


[8]ページ先頭

©2009-2026 Movatter.jp